Source: Eur Respir J 2015; 46: 1223-1225
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Diamant Zuzana, van Maaren Maurits, van Wijk Roy Gerth, Brouwers Jacobus R.B.J., Pieterse Herman. Guidance for the regulatory status of allergen extracts in clinical trials. Eur Respir J 2015; 46: 1223-1225

Member's Comments

No comment yet.

Related content which might interest you: Allergen specific immunotherapy: Effect on immunological markers and clinical outcomes in asthmatic children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 The association between clinical features of asthma and impact of one-year sublingual immunotherapy on immunological system of atopic children Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Publication rate and characteristics of industry-sponsored asthma clinical trials Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Evaluation of data requirements to establish biologic quality control ranges in a multi-center clinical trial for inhaled insulin Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008 Confirmed clinical safety and efficacy of grass allergen tablets Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005 Safety of formoterol in asthma clinical trials: an update Source: Eur Respir J 2014; 43: 103-114 Year: 2004 Evaluation and efficacy of allergen immunotherapy in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 399s Year: 2005 Key role of patients in clinical trials Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Allergy training for health professionals improves quality of life in patients with perennial rhinitis: randomised controlled trial Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care Year: 2005 Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Efficacy of Russian immunologic skin test recombinant allergen Diaskintest - ten years (meta-analysis data) Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 The effectiveness of different clinical measures in evaluating response to omalizumab Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Clinical trials based on biomarkers Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 A randomized double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic rhinitis: effects on clinical and inflammatory markers Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001